51 research outputs found
Asociación Europea de Urología: Declaración de postura sobre el cribado del cáncer prostático
n/
Programmable models of growth and mutation of cancer-cell populations
In this paper we propose a systematic approach to construct mathematical
models describing populations of cancer-cells at different stages of disease
development. The methodology we propose is based on stochastic Concurrent
Constraint Programming, a flexible stochastic modelling language. The
methodology is tested on (and partially motivated by) the study of prostate
cancer. In particular, we prove how our method is suitable to systematically
reconstruct different mathematical models of prostate cancer growth - together
with interactions with different kinds of hormone therapy - at different levels
of refinement.Comment: In Proceedings CompMod 2011, arXiv:1109.104
Burden of metastatic bone disease from genitourinary malignancies.
Item does not contain fulltextBone metastases are common among patients with stage IV genitourinary cancers. Most patients with bone metastases develop at least one debilitating and potentially life-limiting skeletal-related event. These events are associated with increased medical expenses and decreased quality of life. Current guidelines recommend screening for bone metastases in men with high-risk prostate cancer, but guidance for screening and treatment of bone metastases from genitourinary cancers varies by country and setting. Several bisphosphonates have been evaluated in the advanced genitourinary cancer setting. Zoledronic acid has demonstrated efficacy in significantly reducing the risk of skeletal-related events in patients with bone metastases from a broad range of solid tumors including prostate, renal and bladder cancers, and is recommended for preserving bone health.1 november 201
European Association of Urology. Position statement on screening for prostate cancer
European association of urology. position statement on screening for prostate cancer (Editorial)
Asociación Europea de Urología. Declaración de postura sobre el cribado del cáncer prostático
n/
125The 5α-reductase type II A49T and V89L allelic variants are more common in men with prostate cancer compared with the general population
511 SOMATOSTATIN IS EXPRESSED IN THE HUMAN PROSTATE STEM CELL NICHE AND INHIBITS EXPANSION OF LUMINAL PRECURSOR CELLS
- …